Why the study?
Do positive inotropic agents (ouabain and isoproterenol) alter the conformational state of the Na+/Ca2+ exchanger Ca2+-binding domain in transgenic zebrafish hearts?
Do positive inotropic agents (ouabain and isoproterenol) alter the conformational state of the Na+/Ca2+ exchanger Ca2+-binding domain in transgenic zebrafish hearts?
Positive inotropic agents increase intracellular Ca2+ transients and activate the Na+/Ca2+ exchanger by inducing conformational changes in its Ca2+-binding domain in vivo.
Supports NCX conformational activation by inotropes in zebrafish; hypothesis-generating with unclear relevance to human myocardium.
The Na(+)/Ca(2+) exchanger is the major Ca(2+) extrusion mechanism in cardiac myocytes. The activity of the cardiac Na(+)/Ca(2+) exchanger is dynamically regulated by intracellular Ca(2+). Previous studies indicate that Ca(2+) binding to a high-affinity Ca(2+)-binding domain (CBD1) in the large intracellular loop is involved in regulation. We generated transgenic zebrafish with cardiac-specific expression of CBD1 linked to yellow and cyan fluorescent protein. Ca(2+) binding to CBD1 induces conformational changes, as detected by fluorescence resonance energy transfer. With this transgenic fish model, we were able to monitor conformational changes of the Ca(2+) regulatory domain of Na(+)/Ca(2+) exchanger in intact hearts. Treatment with the positive inotropic agents ouabain and isoproterenol increased both Ca(2+) transients and Ca(2+)-induced changes in fluorescence resonance energy transfer. The results indicate that Ca(2+) regulation of the Na(+)/Ca(2+) exchanger domain CBD1 changes with inotropic state. The transgenic fish models will be useful to further characterize the regulatory properties of the Na(+)/Ca(2+) exchanger in vivo.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: